ATE458049T1 - In prostatakrebs exprimiertes gen - Google Patents
In prostatakrebs exprimiertes genInfo
- Publication number
- ATE458049T1 ATE458049T1 AT99950130T AT99950130T ATE458049T1 AT E458049 T1 ATE458049 T1 AT E458049T1 AT 99950130 T AT99950130 T AT 99950130T AT 99950130 T AT99950130 T AT 99950130T AT E458049 T1 ATE458049 T1 AT E458049T1
- Authority
- AT
- Austria
- Prior art keywords
- prostate cancer
- gene
- prostate
- expressed
- gene expressed
- Prior art date
Links
- 108090000623 proteins and genes Proteins 0.000 title abstract 5
- 206010060862 Prostate cancer Diseases 0.000 title abstract 3
- 208000000236 Prostatic Neoplasms Diseases 0.000 title abstract 3
- 208000023958 prostate neoplasm Diseases 0.000 abstract 2
- 210000001550 testis Anatomy 0.000 abstract 2
- 210000001519 tissue Anatomy 0.000 abstract 2
- 239000002299 complementary DNA Substances 0.000 abstract 1
- 239000003550 marker Substances 0.000 abstract 1
- 108020004999 messenger RNA Proteins 0.000 abstract 1
- 210000002307 prostate Anatomy 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/902—Specified use of nanostructure
- Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
- Y10S977/908—Mechanical repair performed/surgical
- Y10S977/91—Strengthening cell or tissue
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/902—Specified use of nanostructure
- Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
- Y10S977/915—Therapeutic or pharmaceutical composition
- Y10S977/916—Gene therapy
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/902—Specified use of nanostructure
- Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
- Y10S977/924—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis using nanostructure as support of dna analysis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10257298P | 1998-09-30 | 1998-09-30 | |
| US14658499P | 1999-07-28 | 1999-07-28 | |
| PCT/US1999/023005 WO2000018925A1 (en) | 1998-09-30 | 1999-09-30 | Gene expressed in prostate cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE458049T1 true ATE458049T1 (de) | 2010-03-15 |
Family
ID=26799520
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99950130T ATE458049T1 (de) | 1998-09-30 | 1999-09-30 | In prostatakrebs exprimiertes gen |
Country Status (12)
| Country | Link |
|---|---|
| US (4) | US6509458B1 (de) |
| EP (2) | EP1117783B1 (de) |
| AT (1) | ATE458049T1 (de) |
| AU (2) | AU764096B2 (de) |
| CA (1) | CA2344620A1 (de) |
| CY (1) | CY1110029T1 (de) |
| DE (1) | DE69942031D1 (de) |
| DK (2) | DK1117783T3 (de) |
| ES (1) | ES2339726T3 (de) |
| IL (2) | IL142194A0 (de) |
| PT (1) | PT1117783E (de) |
| WO (1) | WO2000018925A1 (de) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2339726T3 (es) | 1998-09-30 | 2010-05-24 | Agensys, Inc. | Gen expresado en el cancer de protata. |
| AU5416700A (en) * | 1999-05-20 | 2000-12-12 | Fahri Saatcioglu | Differentially expressed genes in prostate cancer |
| US7189565B2 (en) * | 2001-03-23 | 2007-03-13 | Fahri Saatcioglu | Prostate-specific or testis-specific nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| US7611892B2 (en) * | 2000-03-24 | 2009-11-03 | President And Fellows Of Harvard College | Prostate-specific or testis-specific nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| US7041456B2 (en) * | 2002-04-03 | 2006-05-09 | Syngenta Participations Ag | Detection of wheat and barley fungal pathogens which are resistant to certain fungicides using the polymerase chain reaction |
| JP2004048317A (ja) * | 2002-07-11 | 2004-02-12 | Pioneer Electronic Corp | ノイズ抑圧機能付きデジタル放送受信機 |
| US7192709B2 (en) * | 2004-03-15 | 2007-03-20 | Digigenomics Co., Ltd. | Methods for identification, assessment, prevention, and therapy of cancer |
| US8642664B2 (en) | 2007-08-06 | 2014-02-04 | Samir Mitragotri | Composition for solubilizing tissue and cells comprising N-tetradecyl-N,N-dimethyl-3-ammonio-1-propanesulfonate and polyoxyethylene (10) cetyl ether |
| US9814422B2 (en) | 2007-08-06 | 2017-11-14 | The Regents Of The University Of California | Compositions for solubilizing cells and/or tissue |
| WO2009048681A2 (en) * | 2007-08-06 | 2009-04-16 | The Regents Of The University Of California | Methods of tissue-based diagnosis |
| US8389582B2 (en) | 2007-08-06 | 2013-03-05 | Samir Mitragotri | Composition for solubilizing tissue comprising 3-(decyl dimethyl ammonio) propane sulfonate and tetraethylene glycol dodecyl ether |
| US8609041B2 (en) | 2007-08-06 | 2013-12-17 | Samir Mitragotri | Apparatus for solubilizing tissue |
| US9332973B2 (en) | 2008-10-01 | 2016-05-10 | Covidien Lp | Needle biopsy device with exchangeable needle and integrated needle protection |
| US9186128B2 (en) | 2008-10-01 | 2015-11-17 | Covidien Lp | Needle biopsy device |
| US9782565B2 (en) | 2008-10-01 | 2017-10-10 | Covidien Lp | Endoscopic ultrasound-guided biliary access system |
| US11298113B2 (en) | 2008-10-01 | 2022-04-12 | Covidien Lp | Device for needle biopsy with integrated needle protection |
| US8968210B2 (en) * | 2008-10-01 | 2015-03-03 | Covidien LLP | Device for needle biopsy with integrated needle protection |
| ES2799891T3 (es) * | 2009-02-13 | 2020-12-22 | Univ California | Dispositivo, composición y método para el diagnóstico basado en tejidos |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU1830195A (en) * | 1994-12-15 | 1996-07-03 | Human Genome Sciences, Inc. | Prostatic growth factor |
| US5912143A (en) * | 1996-12-27 | 1999-06-15 | Incyte Pharmaceuticals, Inc. | Polynucleotides encoding a human mage protein homolog |
| EP2343085B1 (de) | 1997-03-10 | 2014-12-10 | The Regents of The University of California | Antikörper gegen das Prostata-Stammzellantigen (PSCA) |
| AU8151898A (en) * | 1997-06-20 | 1999-01-04 | Human Genome Sciences, Inc. | Lyme disease vaccines |
| US5922546A (en) | 1997-08-25 | 1999-07-13 | Smithkline Beecham Corporation | Human disintegrin metalloprotease KUZ gene |
| WO2000000605A1 (en) * | 1998-06-29 | 2000-01-06 | Myriad Genetics, Inc. | Tmprss2 is a tumor suppressor |
| ES2339726T3 (es) | 1998-09-30 | 2010-05-24 | Agensys, Inc. | Gen expresado en el cancer de protata. |
| US7368527B2 (en) * | 1999-03-12 | 2008-05-06 | Human Genome Sciences, Inc. | HADDE71 polypeptides |
| WO2000061779A1 (en) | 1999-04-09 | 2000-10-19 | Human Genome Sciences, Inc. | 49 human secreted proteins |
| WO2001053836A2 (en) | 2000-01-24 | 2001-07-26 | Millennium Pharmaceuticals, Inc. | Identification, assessment, prevention, and therapy of prostate cancer |
-
1999
- 1999-09-30 ES ES99950130T patent/ES2339726T3/es not_active Expired - Lifetime
- 1999-09-30 EP EP99950130A patent/EP1117783B1/de not_active Expired - Lifetime
- 1999-09-30 EP EP10000495A patent/EP2182064B1/de not_active Expired - Lifetime
- 1999-09-30 CA CA002344620A patent/CA2344620A1/en not_active Abandoned
- 1999-09-30 DE DE69942031T patent/DE69942031D1/de not_active Expired - Lifetime
- 1999-09-30 IL IL14219499A patent/IL142194A0/xx unknown
- 1999-09-30 DK DK99950130.7T patent/DK1117783T3/da active
- 1999-09-30 PT PT99950130T patent/PT1117783E/pt unknown
- 1999-09-30 AU AU62855/99A patent/AU764096B2/en not_active Ceased
- 1999-09-30 WO PCT/US1999/023005 patent/WO2000018925A1/en not_active Ceased
- 1999-09-30 AT AT99950130T patent/ATE458049T1/de active
- 1999-09-30 US US09/410,132 patent/US6509458B1/en not_active Expired - Lifetime
- 1999-09-30 DK DK10000495.1T patent/DK2182064T3/da active
-
2001
- 2001-03-22 IL IL142194A patent/IL142194A/en not_active IP Right Cessation
-
2002
- 2002-12-30 US US10/334,561 patent/US7432346B2/en not_active Expired - Fee Related
-
2003
- 2003-11-03 AU AU2003259622A patent/AU2003259622B2/en not_active Ceased
-
2008
- 2008-09-16 US US12/211,702 patent/US7803916B2/en not_active Expired - Fee Related
-
2010
- 2010-05-14 CY CY20101100417T patent/CY1110029T1/el unknown
- 2010-06-28 US US12/825,078 patent/US7968283B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP1117783A1 (de) | 2001-07-25 |
| AU2003259622B2 (en) | 2006-07-06 |
| DK1117783T3 (da) | 2010-05-17 |
| IL142194A0 (en) | 2002-03-10 |
| DK2182064T3 (da) | 2012-12-17 |
| US20100303845A1 (en) | 2010-12-02 |
| CA2344620A1 (en) | 2000-04-06 |
| CY1110029T1 (el) | 2015-01-14 |
| US7803916B2 (en) | 2010-09-28 |
| PT1117783E (pt) | 2010-04-15 |
| DE69942031D1 (de) | 2010-04-01 |
| AU6285599A (en) | 2000-04-17 |
| US6509458B1 (en) | 2003-01-21 |
| EP2182064B1 (de) | 2012-08-29 |
| US7432346B2 (en) | 2008-10-07 |
| US7968283B2 (en) | 2011-06-28 |
| EP2182064A1 (de) | 2010-05-05 |
| IL142194A (en) | 2010-12-30 |
| AU764096B2 (en) | 2003-08-07 |
| US20030211520A1 (en) | 2003-11-13 |
| AU2003259622A1 (en) | 2003-11-20 |
| ES2339726T3 (es) | 2010-05-24 |
| EP1117783B1 (de) | 2010-02-17 |
| WO2000018925A1 (en) | 2000-04-06 |
| US20090098629A1 (en) | 2009-04-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69942031D1 (de) | In prostatakrebs exprimiertes gen | |
| CY1111147T1 (el) | Διαμεμβρανικο αντιγονο λεκτινης τυπου c εκφραζομενο σε καρκινο στον προστατη ανθρωπου και χρησεις αυτου | |
| WO2002046477A3 (en) | Endogenous retroviruses up-regulated in prostate cancer | |
| WO2001072962A3 (en) | Novel prostate-specific or testis-specific nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods | |
| NO20010196D0 (no) | Sammensetninger og fremgangsmåter for terapi og diagnose av prostatakreft | |
| AU2003253986A1 (en) | Gene expression profiling in biopsied tumor tissues | |
| GR3036047T3 (en) | Inherited and somatic mutations of apc gene in colorectal cancer of humans. | |
| ATE438719T1 (de) | Spezifischer marker für prostatakrebs | |
| PL356908A1 (en) | Compositions and methods for the therapy and diagnosis of prostate cancer | |
| DK1109021T3 (da) | Snail, en ny tumoral progressionsmarkör og et targetprotein for nye antitumorale forbindelser | |
| ITMI962745A0 (it) | Sonda-catetere per il trattamento di tumori di organi parenchimatosi con ipertermia interstiziale indotta da radiofrequenza | |
| ATE341639T1 (de) | Adenovirus-vermittelte gentherapie | |
| WO1999002704A3 (en) | Dual specifically phosphatase and methods of use | |
| WO2003070889A3 (en) | Prostate specific genes and the use thereof in design or therapeutics | |
| AU5302599A (en) | Method for diagnosing bone metastasis of malignant tumor | |
| EP2365081A3 (de) | 13-Transmembrane Protein welches in Prostatakrebs exprimiert wird | |
| ATE501255T1 (de) | 84p2a9: prostata- und hodenspezifisches protein, das sehr stark bei prostatakrebs vorkommt | |
| EP0925074A4 (de) | Umkehr eines krebsphenotyps durch expressionsinhibierung von prostatatumor-induzierenden genen | |
| WO2002008456A3 (de) | Verfahren zur identifizierung metastasierender tumorzellen | |
| WO2002085286A8 (en) | Methods of using secondary lymphoid organ chemokine to modulate physiological processes in mammals | |
| IL142311A0 (en) | Methods and compositions for the diagnosis and therapy of prostate cancer | |
| AU2002243918A1 (en) | Methods for the treatment and diagnosis of prostate cancer based on p75ntr tumor | |
| AU2003282069A8 (en) | Tumor marker proteins for diagnosis and therapy of cancer and cancer risk assessment | |
| SADAHIRO et al. | A CLINICOPATHOLOGICAL STUDY OF CASES WITH CANCER OF UNKNOWN ORIGIN ANALYSIS OF CELLULAR PROTEINS IN PRIMARY AND METASTATIC CANCEROUS TISSUE |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1117783 Country of ref document: EP |